Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Urology|August 1, 1994
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladderA S Sarkis, G Dalbagni, C Cordon-Cardo, et al.
Cancer|March 1, 1991
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989)R J Motzer, N L Geller, C C Tan, et al.
The Journal of Urology|February 1, 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformationJ Sheinfeld, V E Reuter, M R Melamed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancerZ F Zhang, A S Sarkis, C Cordon-Cardo, et al.
The Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patientsR J Motzer, M Mazumdar, J Sheinfeld, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Pageof 10